High-Dose Flu Shot Boosts Protection for Seniors

New findings suggest that high-dose flu vaccines provide enhanced protection for adults aged 65 and older, especially those with chronic lung diseases. The FLUNITY-HD study indicated an 8.8% reduction in hospital admissions for flu or pneumonia among seniors receiving the high-dose vaccine compared to the standard version.

These enhanced vaccines, including Fluzone High-Dose, Flublok, and Fluad, are recommended by the CDC for older adults due to their potentially stronger immune response. This is particularly important as the immune systems of older individuals may not be as robust.

For individuals with lung conditions like asthma or COPD, the risk of severe flu complications, including pneumonia, is significantly higher. A high-dose vaccine can offer crucial additional protection, reducing the likelihood of hospitalization for these vulnerable patients.

While enhanced flu vaccines are not yet broadly recommended for younger individuals with chronic conditions, they are approved for adults 18-64 who have had a solid organ transplant and are on immunosuppressants. The CDC advises seniors to seek out these enhanced vaccines when available for optimal protection this flu season.